Raymond James Financial Services Advisors’s 89bio ETNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$1.29M Buy
174,857
+38,386
+28% +$323K ﹤0.01% 1995
2024
Q2
$1.09M Buy
136,471
+19,166
+16% +$171K ﹤0.01% 2027
2024
Q1
$1.37M Buy
117,305
+13,019
+12% +$144K ﹤0.01% 1871
2023
Q4
$1.16M Sell
104,286
-27,819
-21% -$256K ﹤0.01% 1897
2023
Q3
$2.04M Sell
132,105
-23,423
-15% -$393K ﹤0.01% 1499
2023
Q2
$2.95M Buy
155,528
+46,562
+43% +$818K 0.01% 1302
2023
Q1
$1.66M Buy
108,966
+6,189
+6% +$80.7K ﹤0.01% 1599
2022
Q4
$1.31M Sell
102,777
-57,417
-36% -$517K ﹤0.01% 1677
2022
Q3
$928K Buy
+160,194
New +$704K ﹤0.01% 1852

Other funds holding ETNB

Raymond James Financial Services Advisors's ETNB Position: Q3 2024 in Review

Raymond James Financial Services Advisors increased its 89bio (ETNB) stake by 28% in Q3 2024, buying an estimated $323K and bringing the position to 174,857 shares worth $1.29M. The position accounts for ﹤0.01% of the portfolio, ranked #1995.

Raymond James Financial Services Advisors first reported a position in ETNB in Q3 2022 and has held it in 9 quarters since. The position peaked at $2.95M in Q2 2023. 144 funds tracked by Wall St. Rank hold ETNB as of Q3 2024.

  • Raymond James Financial Services Advisors held 174,857 shares of 89bio worth $1.29M as of Q3 2024.
  • Raymond James Financial Services Advisors bought 38,386 89bio shares in Q3 2024, an estimated $323K.
  • 89bio made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #1995 holding.
  • Raymond James Financial Services Advisors first reported a position in 89bio in Q3 2022 and has held it in 9 quarters since.
  • Raymond James Financial Services Advisors's 89bio position peaked at $2.95M in Q2 2023.
  • 144 funds tracked by Wall St. Rank held 89bio as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.